论文部分内容阅读
Purose: The main purpose of this study was to assess the efficacy and safety of Travoprost 0.004% (Travatan, Alcon) as monotherapy or additional to Timolol 0.5% therapy in patients with Primary Open Angle Glaucoma /POAG/. Methods: Twenty patients with POAG underwent treatment with Travoprost 0.004% (Travatan, Alcon). All patients, treated with Timolol
Purose: The main purpose of this study was to assess the efficacy and safety of Travoprost 0.004% (Travatan, Alcon) as monotherapy or additional to Timolol 0.5% therapy in patients with Primary Open Angle Glaucoma / POAG /. Methods: Twenty patients with POAG underwent treatment with Travoprost 0.004% (Travatan, Alcon). All patients, treated with Timolol